Getz Pharma Pakistan (Pvt) Ltd
Sofiget 400mg Tab 28's
Sofosbuvir 400 mg
Inclusive of all taxes · Pack of 28 Tab
Frequently asked
Can I take this medicine with food?
Yes, it can be taken with or without food.Can I stop taking the medication when I feel better?
No — you should NOT stop this medicine on your own even if you feel better.What happens if I take too much?
Possible Effects of Overdose: Severe fatigue or weakness Headache Nausea or vomiting Dizziness Sleep disturbance Worsening of liver function (in patients with liver disease)
Verified by Ailaaj Pharmacist
Licensed · DRAP-compliant
All products are sourced from DRAP-licensed suppliers and verified by our in-house pharmacists before dispatch.
View trust & licensingProduct overview
Product Summary:
Sofiget 400 mg (Sofosbuvir) is an antiviral medicine used for the treatment of chronic Hepatitis C infection. It works by blocking the Hepatitis C virus (HCV) replication enzyme (NS5B polymerase), preventing the virus from multiplying in the body.
Who It's For:
Patients diagnosed with Chronic Hepatitis C (HCV infection) Adults requiring antiviral therapy as part of combination treatment Patients with or without liver cirrhosis (as advised by specialist)
Key Benefits:
Helps achieve sustained virologic response (SVR) → cure of HCV in many cases Stops viral replication Reduces risk of liver cirrhosis progression Lowers risk of liver failure and hepatocellular carcinoma (HCC) Well-tolerated with short treatment duration compared to older therapies
- Generic name
- Sofosbuvir 400 mg
- Manufacturer
- Getz Pharma Pakistan (Pvt) Ltd
- Form
- Tablet
- Pack size
- Pack of 28 Tab
- Prescription
- Not required (OTC)
- MRP
- Rs.6,954.92
Uses
Primary Use:
Treatment of Chronic Hepatitis C infection
Also Used For:
Combination antiviral therapy for different HCV genotypes Patients with liver fibrosis or cirrhosis due to HCV Pre/post liver transplant HCV management (specialist-guided)
Who May Benefit:
Patients with confirmed Hepatitis C infection Individuals needing curative antiviral therapy Patients with liver disease due to HCV Those suitable for direct-acting antiviral regimens
Warnings & interactions
Warnings:
Must always be used in combination therapy (not alone) Risk of hepatitis B reactivation in co-infected patients Monitor liver function during therapy May cause fatigue, headache, anemia (if combined with ribavirin) Dose adjustment may be required in severe renal impairment (depending on regimen)
Avoid If:
Known hypersensitivity to sofosbuvir Monotherapy use (ineffective alone) Pregnancy (only if combination therapy clearly required; avoid ribavirin-containing regimens in pregnancy) Severe drug interactions without specialist guidance
Interactions:
Amiodarone (risk of severe bradycardia) Rifampin / Rifabutin / Rifapentine (reduces efficacy) Carbamazepine, phenytoin, phenobarbital (reduce antiviral levels) St. John’s Wort (contraindicated) Other antiviral combinations (daclatasvir, ledipasvir, velpatasvir – used intentionally as regimen)
Common side effects
Headache, Fatigue, Nausea
Generic & branded alternatives
Same active ingredients — verified equivalents you can switch to.
